Tumor-infiltrating T lymphocytes in patients with non-small cell lung cancer express high levels of Tim-3 and blocking Tim-3 effectively restores the secretion of IFN-γ and TNF-α of CD8+ T cells (14). This evidence concerns the gene HAVCR2 and neoplasm.